The effect of exercise on chemotherapy completion rates in cancer patients receiving adjuvant chemotherapy - The ChemoFit Study
- Conditions
- CancerCancer - BreastCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Lung - Non small cellCancer - Other cancer types
- Registration Number
- ACTRN12623000888662
- Lead Sponsor
- Cabrini Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 252
1) Diagnosed with a solid tumour (stages I-III),
2) Scheduled for first-line adjuvant chemotherapy with curative intent,
3) Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2,
4) Greater than or equal to 18 years of age.
1) Other actively treated cancer (expect for non-melanoma skin cancer),
2) Having received chemotherapy previously,
3) Any medical condition that could place the participant at unreasonable risk of injury or illness caused by the exercise testing or training;
4) Pregnant
5) Unable to read, speak or understand English (and no interpreter).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemotherapy completion rate will be assessed as the relative dose intensity (RDI) extracted from patient medical records.[ Post-assessment: following adjuvant chemotherapy (within 4 weeks of the last chemotherapy cycle) or 8 months after the first exercise session, whichever comes first.]
- Secondary Outcome Measures
Name Time Method